Femme et Homme
- | Pays :
- Austria
- | Organes : -
- | Spécialités : -
Extrait
This study evaluated the efficacy and safety of Avastin (bevacizumab, 5 mg/kg intravenously every 2 weeks) in patients with multiple myeloma, relapsed/refractory after at least 2 lines of prior therapy.
Critère d'inclusion
- Multiple myeloma